Stephen Oesterle

Stephen Oesterle is a Senior Advisor at Patient Square Capital and an advisor to several global private equity groups. Prior to his current advisory roles, he served as Senior Vice President of Medicine and Technology at Medtronic plc until his retirement in 2015, directing the corporation's scientific research and technology investments. An interventional cardiologist by training, he previously directed clinical cardiology programs at Stanford University and Massachusetts General Hospital after earning his medical degree from the Yale School of Medicine in 1977. He currently holds public board director positions at Baxter International, Paragon 28, and Peijia Medical, while also advising major investment entities such as Temasek Holdings, EQT, and Verily Life Sciences. His professional background focuses entirely on the intersection of clinical medicine, medical device innovation, and venture capital investments within the emerging healthcare sector.